Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy

Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy Write my paper based on these questions below. ? What type of data is being assessed (nominal, ordinal, continuous) ? Are the statistical tests used to evaluate the data appropriate ? Is the effect size clinically relevant ? Evaluate the results in absolute values and calculate number needed to treat (NNT), if applicable. ? Were subgroups and/or secondary endpoints evaluated? If so what significance can we take from them? ? What type of data is being analyzed? ? Is the data parametric or non-parametric? ? Is the data paired or unpaired? ? Is the test appropriate for the data? ? What is the sample size? ? Is the study enrollment enough to detect a difference? ? What endpoint(s) was the trial powered to detect? ? Is the effect size clinically relevant? ? Can you calculate a NNT? ? Can you calculate a NNH? ? Was it an ITT or per-protocol analysis? How does this impact the analysis of the results? ? Were subgroups analyzed? Were these analyses planned a priori? Are the results of these subgroup analyses valid/generalizable? ? Do patients need to be stratified? PLACE THIS ORDER OR A SIMILAR ORDER WITH US TODAY AND GET AN AMAZING DISCOUNT :)